search
Back to results

Concomitant Tricuspid Repair in Patients With Left Heart Surgery

Primary Purpose

Tricuspid Regurgitation, Mitral Regurgitation, Cardiopulmonary Bypass

Status
Not yet recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Tricuspid repair
Sponsored by
Nanjing Medical University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Tricuspid Regurgitation

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patients undergoing left heart valve surgery with mild tricuspid regurgitation;
  2. Patients aged 18-80 years;
  3. Agree to participate in this study and sign the informed consent form.

Exclusion Criteria:

  1. Infective endocarditis within 3 months;
  2. Primary tricuspid regurgitation;
  3. Isolated tricuspid regurgitation
  4. Lactating women and suspected pregnant or pregnant women;
  5. Patients with mental disorders, drug and alcohol dependence;
  6. Those who participated in other clinical trials one month before the trial;
  7. Refusal to participate in this study without informed consent.

Sites / Locations

  • The First Affiliated Hospital of Nanjing Medical University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Tricuspid repair

Blank control

Arm Description

Tricuspid repair techniques included suture placement and the type of prosthetic annuloplasty with specified the use of an approved rigid, incomplete, nonplanar, and undersized (ranging 26, 28, or 30, 32, 34 mm) ring.

Outcomes

Primary Outcome Measures

A composite of adverse cardiovascular events
a composite of reoperation for tricuspid regurgitation, progression of tricuspid regurgitation from baseline by two grades or the presence of severe tricuspid regurgitation, or death.

Secondary Outcome Measures

Full Information

First Posted
October 23, 2022
Last Updated
October 23, 2022
Sponsor
Nanjing Medical University
Collaborators
Affiliated Hospital of Nantong University, The First Affiliated Hospital of Anhui Medical University, Jiangsu Subei People Hospital, Nanjing First Hospital, Nanjing Medical University
search

1. Study Identification

Unique Protocol Identification Number
NCT05595187
Brief Title
Concomitant Tricuspid Repair in Patients With Left Heart Surgery
Official Title
Concomitant Tricuspid Repair in Patients With Left Heart Surgery: Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
December 1, 2022 (Anticipated)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Nanjing Medical University
Collaborators
Affiliated Hospital of Nantong University, The First Affiliated Hospital of Anhui Medical University, Jiangsu Subei People Hospital, Nanjing First Hospital, Nanjing Medical University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Tricuspid regurgitation is common in patients with severe left heart diseases, such as degenerative mitral regurgitation. However, the evidence base is insufficient to inform a decision about whether to perform concomitant tricuspid-valve repair during left heart surgery in patients who have mild tricuspid regurgitation. To inform decision making, we will conduct a multicenter, randomized trial to assess the benefits and risks of tricuspid-valve repair at the time of left heart diseases in patients with mild tricuspid regurgitation who were undergoing surgery for left heart surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tricuspid Regurgitation, Mitral Regurgitation, Cardiopulmonary Bypass

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
400 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Tricuspid repair
Arm Type
Experimental
Arm Description
Tricuspid repair techniques included suture placement and the type of prosthetic annuloplasty with specified the use of an approved rigid, incomplete, nonplanar, and undersized (ranging 26, 28, or 30, 32, 34 mm) ring.
Arm Title
Blank control
Arm Type
No Intervention
Intervention Type
Device
Intervention Name(s)
Tricuspid repair
Intervention Description
Tricuspid repair included suture placement and the type of prosthetic annuloplasty.
Primary Outcome Measure Information:
Title
A composite of adverse cardiovascular events
Description
a composite of reoperation for tricuspid regurgitation, progression of tricuspid regurgitation from baseline by two grades or the presence of severe tricuspid regurgitation, or death.
Time Frame
2 years after surgery at follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients undergoing left heart valve surgery with mild tricuspid regurgitation; Patients aged 18-80 years; Agree to participate in this study and sign the informed consent form. Exclusion Criteria: Infective endocarditis within 3 months; Primary tricuspid regurgitation; Isolated tricuspid regurgitation Lactating women and suspected pregnant or pregnant women; Patients with mental disorders, drug and alcohol dependence; Those who participated in other clinical trials one month before the trial; Refusal to participate in this study without informed consent.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hong Liu, MD
Phone
18801281613
Email
dr.hongliu@foxmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Yong-feng Shao, MD
Phone
02568303101
Email
yfshaojph@sina.com
Facility Information:
Facility Name
The First Affiliated Hospital of Nanjing Medical University
City
Nanjing
Country
China

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Concomitant Tricuspid Repair in Patients With Left Heart Surgery

We'll reach out to this number within 24 hrs